Rubric Capital Management LP Coherus Bio Sciences, Inc. Call Options Transaction History
Rubric Capital Management LP
- $3.49 Billion
- Q1 2025
Call Options
1 transactions
Others Institutions Holding CHRS
# of Institutions
123Shares Held
64.5MCall Options Held
96.6KPut Options Held
65.3K-
Black Rock Inc. New York, NY11.8MShares$9.52 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.2MShares$9.03 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA5.1MShares$4.13 Million0.27% of portfolio
-
Kohlberg Kravis Roberts & Co. L.P. New York, NY3.04MShares$2.46 Million0.11% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.9MShares$2.35 Million0.0% of portfolio
About Coherus BioSciences, Inc.
- Ticker CHRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,724,600
- Market Cap $63M
- Description
- Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...